Emily's Entourage

Personal background

Kramer-Golinkoff was born on January 9, 1985. At six weeks old, she was diagnosed with CF. At a young age, her mother, Liza, would pound on her chest for 45 minutes to loosen the mucus in her lungs."

Today, her lungs function at about one third of the normal lung function. Emily undergoes a daily regimen of three-to-four hours of "airway clearance and breathing treatments" in addition to taking approximately 30 pills and four shots of insulin.

Kramer-Golinkoff has a rare form of CF with a high prevalence among Ashkenazi Jews. Emily's mutation belongs to a larger category called nonsense mutations, which affect approximately 10% of CF cases worldwide and account for up to 30% genetic diseases more broadly.

She graduated in 2003 from Lower Merion High School in Ardmore, Pennsylvania. She graduated cum laude from the University of Pennsylvania's Annenberg School for Communication and then completed her master's degree in bioethics at the University of Pennsylvania Perelman School of Medicine in 2009.

Emily's Entourage

Emily's Entourage was founded by Emily, her friends, and her family in December 2011 when Emily and her family sent a video to their friends and family and it raised over $40,000 in one week. College campuses around the country have joined the movement by forming official clubs on campus and throwing annual fundraising benefits. Local groups, such as Lower Merion School District often volunteer with Emily's Entourage.

By May 2015, Emily's Entourage had raised over $1 million.

Research

Emily's Entourage has a Scientific Advisory Board to "set research priorities and vet, approve, and oversee research projects" for the organization. In January, 2014 Emily’s Entourage hosted a research symposium on nonsense mutations in CF with a focus on Emily’s particular rare mutation with leading researchers from biotech, academia, pharma and the Cystic Fibrosis Foundation in partnership with the Penn Orphan Disease Center to spur discovery of new treatments for those with nonsense CF mutations.

Kramer-Golinkoff also published "A Lesson in Participatory Research for a Rare Mutation of Cystic Fibrosis" in the Journal of General Internal Medicine. For her work towards finding new cures, she was honored at the White House as a "Champion of Change". The honor focused on "work being done by patients, researchers, innovators, and advocates who are advancing our understanding of health and disease by harnessing data to take account individual differences in people’s genes, environments, and lifestyles into account to improve patients’ health."

An NF1 clinical trial is undergoing FDA approval. Emily said, “I realized I could wait on the sidelines and pray for a miracle or get into the game and try to make one.”

Media

Emily and Emily's Entourage have received significant regional and national media coverage. The attention has driven donations as well research opportunities and public awareness. Philadelphia Magazine profiled Emily as a "Health Hero" in September 2015. Emily said, "My biggest motivations for working my hardest to stay as healthy as possible — even in the face of an advanced and progressing fatal illness — are my family and friends, this burning desire to do more things and see more places, and the unbelievable Entourage that rallied behind me to give me and so many others real, tangible hope for that chance." People magazine wrote, "Perhaps the most critical of Emily's Entourage's efforts has been its success in putting a beautiful face on an ugly issue. Case in point: The test tubes that fill the testing laboratories at USCF are all marked with random alphanumerical codes – except those marked with Emily's name."

In Philadelphia Style magazine Emily emphasized her organization's personal approach: "We’re trying to use my story to humanize the disease... People really respond to faces and stories and families in a way that’s different. There are so many important causes out there, but we can touch people’s hearts by making them feel like I could be anyone’s daughter or sister or best friend.'" Yahoo! Health profiled Emily. She said, "My disease is progressing and our race is getting more urgent. We’re doing some really groundbreaking work that is changing the paradigm of how research is done, what gets attention, who the players are, and what the pace of progress is. We are constantly pushing the envelope because I literally don’t have time to wait."

CNN also profiled Emily. University of Pennsylvania Physiology professor Kevin Foskett said in the article, "Emily and her family want research focused on her mutation to be as focused and accelerated as possible. At one level, that sounds a little selfish, until you realize that her type of mutation, a 'nonsense' mutation ... is responsible for disease in many other genetically inherited forms of disease... Emily's story is compelling. If you've met Emily... you cant help but become engaged and energized." Emily said in that piece, "Obviously our prayer and dream is to have a breakthrough. But we also realize that it might not happen, or it might not happen in time for me. And I think that in the worst case scenario, even if it never could help me, there is a peace I get from at least knowing I'm doing everything I can, and it's not for lack of trying."